Krilogy Financial’s Novartis NVS Stock Holding History

Krilogy Financial’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14,550	Closed	-$1.19M	–	286
2021 Q3	$1.19M	Buy	14,550 +148	+1%	+$13.3K	0.12%	118
2021 Q2	$1.31M	Buy	14,402 +597	+4%	+$53.2K	0.13%	109
2021 Q1	$1.18M	Buy	13,805 +5,778	+72%	+$519K	0.12%	110
2020 Q4	$758K	Buy	8,027 +473	+6%	+$41.3K	0.09%	145
2020 Q3	$657K	Sell	7,554 -1,461	-16%	-$127K	0.09%	141
2020 Q2	$787K	Buy	+9,015	New	+$778K	0.12%	114
2018 Q4	–	Sell	-1,285	Closed	-$99K	–	495
2018 Q3	$99K	Buy	+1,285	New	+$95K	0.02%	221
2018 Q2	–	Sell	-728	Closed	-$53K	–	474
2018 Q1	$53K	Buy	728 +148	+26%	+$11.3K	0.01%	316
2017 Q4	$44K	Hold	580	–	–	0.01%	344
2017 Q3	$45K	Buy	580 +31	+6%	+$2.34K	0.01%	355
2017 Q2	$41K	Buy	549 +28	+5%	+$1.98K	0.01%	333
2017 Q1	$34K	Hold	521	–	–	0.01%	344
2016 Q4	$34K	Sell	521 -34	-6%	-$2.21K	0.01%	344
2016 Q3	$39K	Hold	555	–	–	0.01%	336
2016 Q2	$41K	Sell	555 -78	-12%	-$5.39K	0.01%	332
2016 Q1	$41K	Buy	633 +212	+50%	+$14.4K	0.02%	292
2015 Q4	$32K	Sell	421 -111	-21%	-$8.82K	0.03%	171
2015 Q3	$44K	Buy	+532	New	+$47.3K	0.02%	220

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Krilogy Financial's NVS Position: Q4 2021 in Review

Krilogy Financial sold out of Novartis (NVS) in Q4 2021, closing a stake of 14,550 shares — an estimated $1.19M sold.

Krilogy Financial first reported a position in NVS in Q3 2015 and held it in 18 quarters. The position peaked at $1.31M in Q2 2021. 1,146 funds tracked by Wall St. Rank hold NVS as of Q4 2021.

Krilogy Financial reported no remaining Novartis position as of Q4 2021 after selling out during the quarter.
Krilogy Financial sold 14,550 Novartis shares in Q4 2021, an estimated $1.19M.
Krilogy Financial first reported a position in Novartis in Q3 2015 and held it in 18 quarters.
Krilogy Financial's Novartis position peaked at $1.31M in Q2 2021.
1,146 funds tracked by Wall St. Rank held Novartis as of Q4 2021.

Based on Krilogy Financial's 13F filing for Q4 2021, filed 27 Jan 2022.